Skip to main content

Humacyte, Inc.

HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001818382

In the last 90 days, Humacyte, Inc. insiders filed 3 open-market purchases and 0 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $57.3M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Humacyte, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of HUMA: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1432162+21
Shares35.8M70.8K42.1M+6.39M (+17.9%)
Value$194.7M$385.4K$212.7M+$18.4M (+9.5%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (46)

Institutions that held Humacyte, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to HUMA in Q4 2024
InstitutionSharesValue% of portfolio
CenterBook Partners LP1,279,839$6.46M0.39%
Franklin Resources Inc433,482$2.19M0.00%
First Trust Advisors LP340,552$1.72M0.00%
LJI Wealth Management, LLC185,000$934.3K0.18%
Walleye Capital LLC106,698$538.8K0.01%
Trilogy Capital Inc.83,500$421.7K0.02%
Raymond James Financial Inc74,698$377.2K0.00%
Jaffetilchin Investment Partners, LLC67,200$339.4K0.02%
Quinn Opportunity Partners LLC65,000$328.3K0.02%
Rockefeller Capital Management L.P.49,662$250.8K0.00%
Uniting Wealth Partners, LLC39,554$199.7K0.10%
Freestone Grove Partners LP38,899$196.4K0.00%
Clarus Wealth Advisors41,063$180.3K0.09%
Thompson Siegel & Walmsley LLC35,000$177.0K0.00%
Rowland & Co Investment Counsel31,500$159.1K0.03%
Zurcher Kantonalbank (Zurich Cantonalbank)29,004$146.5K0.00%
Squarepoint Ops LLC26,098$131.8K0.00%
Atria Wealth Solutions, Inc.25,840$130.5K0.00%
Rossby Financial, LCC25,000$126.3K0.08%
KLP Kapitalforvaltning AS19,600$99.0K0.00%
Police & Firemen's Retirement System of New Jersey17,673$89.2K0.00%
Rather & Kittrell, Inc.17,350$87.6K0.02%
BNP Paribas Arbitrage, SA14,613$73.8K0.00%
Engineers Gate Manager LP14,557$73.5K0.00%
Prelude Capital Management, LLC14,200$71.7K0.01%
HighTower Advisors, LLC13,105$66.2K0.00%
Crestline Management, LP12,976$65.5K0.00%
HSBC Holdings PLC12,417$62.1K0.00%
Ameriprise Financial Inc11,555$58.4K0.00%
Act Wealth Management, LLC11,379$57.5K0.03%
Brookstone Capital Management11,105$56.1K0.00%
Syon Capital LLC10,777$54.4K0.00%
Vontobel Holding Ltd.10,000$50.5K0.00%
Petros Family Wealth, LLC10,000$50.5K0.05%
R Squared Ltd2,950$14.9K0.01%
GF Fund Management Co. Ltd.2,685$13.6K0.00%
Caitong International Asset Management Co., Ltd1,508$7.62K0.01%
Global Retirement Partners, LLC1,480$7.47K0.00%
Stonebridge Financial Group, LLC1,000$5.05K0.00%
Duncker Streett & Co Inc800$4.04K0.00%
MAI Capital Management653$3.30K0.00%
SBI Securities Co., Ltd.252$1.27K0.00%
Northwestern Mutual Wealth Management Co141$7120.00%
Farther Finance Advisors, LLC130$6570.00%
Newbridge Financial Services Group, Inc.60$3030.00%
EverSource Wealth Advisors, LLC3$150.00%

Sold out (25)

Institutions that held Humacyte, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Humacyte, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HUMA in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James & Associates43,278$235.4K
Raymond James Financial Services Advisors, Inc.27,568$150.0K